(Q51049137)
Statements
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer (English)
J A Davidson
I Cromwell
C Lohrisch
K A Gelmon
T Shenkier
D Villa
H Lim
S Sun
S Taylor
M Taylor
B Czerkawski
M Hayes
D N Ionescu
C Yoshizawa
C Chao
20 April 2013